Search

Search Constraints

You searched for: Author/Creator Wahrmann, Markus

Search Results

1. ANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE?. Issue 3 (September 2020)

2. Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena. Issue 2 (26th January 2023)

3. Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial. Issue 10 (October 2017)

4. CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection. Issue 2 (February 2021)

5. Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts. (16th January 2014)

8. Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection. Issue 7 (July 2019)

9. DETECTION OF DONOR-DERIVED CELL-FREE DNA: NON-INVASIVE PREDICTION OF SILENT ANTIBODY-MEDIATED REJECTION IN DONOR-SPECIFIC ANTIBODY-POSITIVE RENAL ALLOGRAFT RECIPIENTS. Issue 3 (September 2020)

10. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection—Results of a Cross-Sectional Screening Study. Issue 3 (March 2017)